Marksans Pharma Ltd. - Research Center
524404 MARKSANS Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 853.27 | 655.20 | 658.29 | 599.55 | 433.42 |
| Expenses | |||||
| Material consumed | 478.94 | 394.45 | 377.59 | 337.91 | 243.03 |
| Manufacturing expenses | 26.04 | 14.24 | 11.27 | 10.90 | 8.95 |
| Personnel expenses | 77.19 | 56.09 | 60.46 | 54.64 | 48.51 |
| Selling expenses | - | - | - | - | - |
| Adminstrative expenses | 131.17 | 98.52 | 95.25 | 82.38 | 61.43 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 713.34 | 563.30 | 544.57 | 485.84 | 361.93 |
| Operating profit | 139.94 | 91.90 | 113.72 | 113.71 | 71.49 |
| Other recurring income | 62.07 | 60.48 | 42.25 | 31.16 | 0.17 |
| Adjusted PBDIT | 202.01 | 152.39 | 155.97 | 144.87 | 71.66 |
| Financial expenses | 0.99 | 3.61 | 3.80 | 5.34 | 7.29 |
| Depreciation | 29.13 | 16.74 | 17.66 | 15.19 | 11.64 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 171.89 | 132.04 | 134.51 | 124.33 | 52.73 |
| Tax charges | 38.13 | 29.17 | 30.52 | 25.95 | 14.82 |
| Adjusted PAT | 133.76 | 102.87 | 103.99 | 98.38 | 37.90 |
| Non recurring items | 0.28 | -0.59 | 0.05 | -0.20 | 0.16 |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 134.04 | 102.28 | 104.03 | 98.19 | 38.07 |
| Earnigs before appropriation | 367.65 | 257.48 | 165.44 | 65.50 | -24.67 |
| Equity dividend | 22.66 | 10.17 | 10.23 | 4.09 | 2.47 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | - | - |
| Retained earnings | 345.00 | 247.31 | 155.21 | 61.41 | -27.14 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis